RELATIONSHIP BETWEEN BLEEDING AND MORTALITY IN PATIENTS ON DUAL ANTIPLATELET THERAPY VS ASPIRIN ALONE: RESULTS FROM THE CHARISMA TRIAL

被引：0
|
作者：
Berger, Jeffrey S. [1 ]
Bhatt, Deepak L. [1 ]
Steg, Gabriel P. [1 ]
Steinhubl, Steven R. [1 ]
Montalescot, Gilles [1 ]
Shao, Mingyuan [1 ]
Hacke, Werner [1 ]
Fox, Keith A. [1 ]
Berger, Peter B. [1 ]
Topol, Eric J. [1 ]
Lincoff, Michael [1 ]
机构：
[1] NYU Sch Med, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 14期
关键词：
D O I：
10.1016/S0735-1097(11)61237-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1237 / E1237
页数：1
相关论文
共 50 条
  • [1] Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Chatterjee, Saurav
    Maitra, Subhankar
    Chakraborty, Anasua
    [J]. AMERICAN HEART JOURNAL, 2012, 163 (01) : E1 - E1
  • [2] Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Berger, Jeffrey S.
    Bhatt, Deepak L.
    Steg, P. Gabriel
    Steinhubl, Steven R.
    Montalescot, Gilles
    Shao, Mingyuan
    Hacke, Werner
    Fox, Keith A.
    Berger, Peter B.
    Topol, Eric J.
    Lincoff, A. Michael
    [J]. AMERICAN HEART JOURNAL, 2011, 162 (01) : 98 - U136
  • [3] Impact of Post-Discharge Dual Antiplatelet Therapy vs. Aspirin Alone After CABG in Patients with Left Main Disease: Results from the EXCEL Trial
    Kelly, Christopher
    Sabik, Joseph
    Kappetein, A. Pieter
    Brown, William
    Noiseux, Nicolas
    Pomar, Jose
    Zhang, Yiran
    Serruys, Patrick
    Stone, Gregg
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B33 - B34
  • [4] Long-term dual antiplatelet therapy and bleeding in stable patients—insights from CHARISMA
    Joana Osório
    [J]. Nature Reviews Cardiology, 2010, 7 (9) : 478 - 478
  • [5] Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
    Moll, Frans
    Baumgartner, Iris
    Jaff, Michael
    Nwachuku, Chuke
    Tangelder, Marco
    Ansel, Gary
    Adams, George
    Zeller, Thomas
    Rundback, John
    Grosso, Michael
    Lin, Min
    Mercur, Michele F.
    Minar, Erich
    [J]. JOURNAL OF ENDOVASCULAR THERAPY, 2018, 25 (02) : 158 - 168
  • [6] Aspirin alone is safer than dual antiplatelet therapy in patients undergoing TAVI
    Andrew Robson
    [J]. Nature Reviews Cardiology, 2020, 17 : 679 - 679
  • [7] An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial
    Wang, Thomas H.
    Bhatt, Deepak L.
    Fox, Keith A. A.
    Steinhubl, Steven R.
    Brennan, Danielle M.
    Hacke, Werner
    Mak, Koon-Hou
    Pearson, Thomas A.
    Boden, William E.
    Steg, P. Gabriel
    Flather, Marcus D.
    Montalescot, Gilles
    Topol, Eric J.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (18) : 2200 - 2207
  • [8] Aspirin alone is safer than dual antiplatelet therapy in patients undergoing TAVI
    Robson, Andrew
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (11) : 679 - 679
  • [9] Cost-effectiveness of clopidogrel plus aspirin vs. aspirin alone for secondary-prevention of cardiovascular events: Results from the CHARISMA trial
    Chen, Jersey
    Bhatt, Deepak L.
    Schneider, Elizabeth
    Shi, Chunxue
    Caro, Jaime
    Proskorovsky, Irina
    Hacke, Werner
    Fox, Keith A.
    Cohen, David J.
    [J]. CIRCULATION, 2006, 114 (18) : 826 - 826
  • [10] Incidence, Predictors, and Outcomes of Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
    Alli, Oluseun
    Smith, Colin
    Hoffman, Micah
    Amanullah, Steven
    Katz, Philip
    Amanullah, Aman M.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (05) : 410 - 414
12345